U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07084909) titled 'Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC' on May 30.
Brief Summary: This study is being conducted to test whether an imaging technique called a "piflufolastat F 18 PET/CT" imaging scan can be used to diagnose and describe the extent of clear cell Renal Carcinoma in patients.
The main questions it aims to answer are:
* What is the most appropriate dose and scan timing window for piflufolastat F 18 PET/CT for patients with clear cell Renal Cell Carcinoma (ccRCC) with known metastatic disease?
* Ability of piflufolastat F 18 PET/CT to detect metastatic of lesions ccRCC in patients wi...